The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Nu Skin Enterprises, Inc (NYSE: NUS) closed at $6.96 in the last session, down -7.57% from day before closing price of $7.53. In other words, the price has decreased by -$7.57 from its previous closing price. On the day, 1.33 million shares were traded. NUS stock price reached its highest trading level at $7.69 during the session, while it also had its lowest trading level at $6.94.
Ratios:
We take a closer look at NUS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.67 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.38. For the most recent quarter (mrq), Quick Ratio is recorded 1.20 and its Current Ratio is at 1.93. In the meantime, Its Debt-to-Equity ratio is 0.71 whereas as Long-Term Debt/Eq ratio is at 0.63.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on January 31, 2023, Downgraded its rating to Hold and sets its target price to $39 from $43 previously.
BofA Securities Upgraded its Underperform to Neutral on October 02, 2020, whereas the target price for the stock was revised from $54 to $58.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 28 ’24 when LIPMAN ANDREW D sold 2,000 shares for $13.33 per share. The transaction valued at 26,660 led to the insider holds 23,225 shares of the business.
WOODBURY EDWINA D sold 1,693 shares of NUS for $20,350 on May 02 ’24. The Director now owns 18,095 shares after completing the transaction at $12.02 per share. On Apr 25 ’24, another insider, LIPMAN ANDREW D, who serves as the Director of the company, sold 2,000 shares for $12.34 each. As a result, the insider received 24,680 and left with 25,225 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NUS now has a Market Capitalization of 374324128 and an Enterprise Value of 632697728. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.22 while its Price-to-Book (P/B) ratio in mrq is 0.49. Its current Enterprise Value per Revenue stands at 0.356 whereas that against EBITDA is 2.854.
Stock Price History:
The Beta on a monthly basis for NUS is 1.17, which has changed by -0.5927528 over the last 52 weeks, in comparison to a change of 0.24933672 over the same period for the S&P500. Over the past 52 weeks, NUS has reached a high of $19.36, while it has fallen to a 52-week low of $5.95. The 50-Day Moving Average of the stock is -1.43%, while the 200-Day Moving Average is calculated to be -28.08%.
Shares Statistics:
According to the various share statistics, NUS traded on average about 824.47K shares per day over the past 3-months and 1096830 shares per day over the past 10 days. A total of 49.70M shares are outstanding, with a floating share count of 48.54M. Insiders hold about 2.35% of the company’s shares, while institutions hold 79.51% stake in the company. Shares short for NUS as of 1734048000 were 1614377 with a Short Ratio of 1.96, compared to 1731628800 on 1794509. Therefore, it implies a Short% of Shares Outstanding of 1614377 and a Short% of Float of 4.6899999999999995.
Dividends & Splits
The forward annual dividend rate for NUS is 0.24, which was 0.57 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.075697206The stock’s 5-year Average Dividend Yield is 4.8.
